CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1131 - 1140 of 1148
Study Number Lead Group Study Title CIRB Study Status
10296 ETCTN Phase Ib/II trial of copanlisib in combination with trastuzumab and pertuzumab after induction treatment of HER2 positive (HER2+) metastatic breast cancer (MBC) with PIK3CA mutation or PTEN mutation Adult CIRB - Early Phase Emphasis Completed
RTOG-0232 RTOG A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone for Selected Patients with Intermediate Risk Prostatic Carcinoma Adult CIRB - Late Phase Emphasis Completed
S0232 SWOG Double-Blinded Placebo Controlled Phase III Trial Comparing Dexamethasone (DEX) to the Combination of DEX + CC-5013 in Patients with Previously Untreated Multiple Myeloma who are Not Immediately Undergoing Autologous Stem Cell Transplant Adult CIRB - Late Phase Emphasis Completed
S0600 SWOG Phase III Trial of Irinotecan-Based Chemotherapy Plus Cetuximab (NSC-714692) or Bevacizumab (NSC-704865) as Second-Line Therapy for Patients with Metastatic Colorectal Cancer who have Progressed on Bevacizumab with either FOLFOX; OPTIMOX or XELOX Adult CIRB - Late Phase Emphasis Completed
ACCL21C2 COG Prospective Cohort Study to Evaluate Immunologic Response Following COVID-19 Vaccination in Children, Adolescents and Young Adults with Cancer Pediatric CIRB Completed
UAZ2017-09-02 CP-CTNet_CLO-University of Arizona Clinical Study of Avmacol® for Detoxification of Tobacco Carcinogens in Heavy Smokers Cancer Prevention and Control CIRB Completed
A211401 Alliance Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes Cancer Prevention and Control CIRB Completed
AALL07P1 COG A Phase II Pilot Trial of Bortezomib (PS-341; Velcade; IND# 58;443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL) Pediatric CIRB Completed
ANBL0931 COG A Comprehensive Safety Trial of Chimeric Antibody 14.18 (ch14.18) with GM-CSF, IL-2 and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy Pediatric CIRB Completed
10130 ETCTN A phase I study of single agent tazemetostat in subjects with advanced solid tumors and B-cell lymphomas with hepatic dysfunction Adult CIRB - Early Phase Emphasis Completed
Displaying 1131 - 1140 of 1148